Alterras Therapeutics GmbH
PrivateLast Round
Corporate Funding
Jul 6, 2021
Total Funding Raised
$77,000
Company Overview
Alterras Therapeutics GmbH operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Corporate Funding round in July 2021.
Alterras Therapeutics GmbH is a biopharmaceutical company that develops therapies targeting the alternative renin-angiotensin system for the treatment of pulmonary hypertension and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Alterras Therapeutics GmbH Comparables
Compare Alterras Therapeutics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| APEPTICO Forschung und Entwicklung GmbH | 77% | |
| Cereno Scientific | 76% | |
| Vicore Pharma | 73% |
For institutional investors. Book with your work email.
Alterras Therapeutics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Jul 6, 2021 | ||||
| Seed | Jun 19, 2020 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 6, 2021
$6K raised in corporate funding.
- Jun 19, 2020
$71K round led by MetaMedical s.r.o.
For institutional investors. Book with your work email.
Alterras Therapeutics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Alterras Therapeutics GmbH's valuation, stock price, and market status.
Is Alterras Therapeutics GmbH a public or private company?
Alterras Therapeutics GmbH is a private company.
What is the current stock price of Alterras Therapeutics GmbH?
Alterras Therapeutics GmbH is a private company, so its shares have no public market price. Caplight tracks Alterras Therapeutics GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Alterras Therapeutics GmbH worth (valuation)?
Valuation information for Alterras Therapeutics GmbH is not publicly available.
Can I buy Alterras Therapeutics GmbH stock?
Alterras Therapeutics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Alterras Therapeutics GmbH's last funding round?
Alterras Therapeutics GmbH's most recent funding round was Corporate Funding on July 6, 2021.
Who are the main investors in Alterras Therapeutics GmbH?
Investor information for Alterras Therapeutics GmbH is not publicly disclosed.
Will Alterras Therapeutics GmbH IPO soon?
No public IPO plans have been announced for Alterras Therapeutics GmbH.
How can I track Alterras Therapeutics GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Alterras Therapeutics GmbH's shares on secondary markets.